Answer
It is unknown whether Extraneal metabolites pass into human breast milk; a risk to newborns or infants cannot be excluded, so stopping breastfeeding or discontinuing/abstaining from Extraneal therapy must be decided by weighing breastfeeding benefits for the child against therapy benefits for the woman.
Sources for this answer
- EXTRANEAL (Icodextrin 7.5%) Solution for peritoneal dialysisVantive Limited · emc · SmPC §4.6 Fertility, pregnancy and lactation · Version 4Document updated
Sources checked